AI Product
Kardia personal ECG devices (KardiaMobile
Kardia personal ECG devices (KardiaMobile, KardiaMobile 6L, Kardia 12L) and KAI AI algorithms detecting arrhythmias, ischemia patterns, and morphology findings; KardiaPro and KardiaStation enterprise software for provider monitoring…
- Status
- Active
- Category
- Medical Devices
- Developer
- AliveCor
- Industry
- AI in Healthcare
- Country
- United States
Product Ecosystem Map
How this product connects across company, capabilities, technology, and markets on Brel.
Overview
What this product is, what it does, and who develops it.
Kardia personal ECG devices (KardiaMobile represents AliveCor's core operational platform for organizations seeking to streamline filtering noisy physiological sensor signals in critical care units. Built to mitigate clinical workflow latency and diagnostic data fragmentation, the software helps enterprise teams realize enabling precise personalized treatment protocol recommendations.
Mountain View AI-powered personal and handheld ECG devices including Kardia 12L with expanding FDA-cleared cardiac determinations
What it does
Kardia personal ECG devices (KardiaMobile, KardiaMobile 6L, Kardia 12L) and KAI AI algorithms detecting arrhythmias, ischemia patterns, and morphology findings; KardiaPro and KardiaStation enterprise software for provider monitoring and clinical trials.
Who develops it
Consumers, employers, health systems, life-sciences sponsors, and veterans health programs needing portable ECG acquisition with AI interpretation in outpatient, acute, and remote monitoring settings.
Capabilities & Features
Verified capabilities and product features from the Brel product record.
Capabilities
- Kardia personal ECG devices (KardiaMobile, KardiaMobile 6L, Kardia 12L) and KAI AI algorithms detecting arrhythmias, isch
- KardiaPro and KardiaStation enterprise software for provider monitoring and clinical trials
Technology & Architecture
Technologies, models, and technical structure linked to this product.
Use Cases
Where this product is applied in real operational contexts.
- Kardia personal ECG devices (KardiaMobile, KardiaMobile 6L, Kardia 12L) and KAI AI algorithms detecting arrhythmias, ischemia patterns, and morphology findings
- KardiaPro and KardiaStation enterprise software for provider monitoring and clinical trials.
- Medical Imaging: Optimizing workflow execution latency and improving throughput.
Who It Is For
Target users, industries, and deployment context.
Consumers, employers, health systems, life-sciences sponsors, and veterans health programs needing portable ECG acquisition with AI interpretation in outpatient, acute, and remote monitoring settings.
Industries
Industries served
- AI in Healthcare
- Medical Devices
Enterprise buyers and technical teams, data leaders, and operational specialists in Healthcare utilize Kardia personal ECG devices (KardiaMobile across mission-critical workflows. Systems administrators can configure the platform within decentralized clinical compute nodes with localized data residency.
Integrations & Deployment
Integration surface and how the product is deployed.
To minimize rollout friction, Kardia personal ECG devices (KardiaMobile provides pre-built connector modules for standard cloud data warehouses, relational storage, and enterprise identity providers.
Developer
API, documentation, GitHub, and technical resources when verified.
Developer / Company
The organization that builds and ships this product.
The engineering behind Kardia personal ECG devices (KardiaMobile is managed by AliveCor, headquartered in Mountain View, United States established in 2011 by David Albert. The platform represents a key product pillar in AliveCor's broader Healthcare strategy.
Recent Organizational Milestones: 2011: AliveCor founded in Mountain View. July 24, 2019: Priya Abani appointed chief executive officer per AliveCor press archive. January 13, 2026: FDA clearance for five additional KAI 12L cardiac determinations; total cleared determinations reach 39. 2025: CMS approved Medicare payment for Kardia 12L in hospital outpatient settings.
Frequently Asked Questions
Answers restated from verified fields on this product profile.
How is Kardia personal ECG devices (KardiaMobile defined?
Kardia personal ECG devices (KardiaMobile is an AI solution developed by AliveCor, designed to deliver standardizing institutional care delivery and clinical audit compliance by systematizing accelerating diagnostic evidence extraction and molecular modeling.
Which company creates and maintains Kardia personal ECG devices (KardiaMobile?
Kardia personal ECG devices (KardiaMobile is built and maintained by AliveCor, based in Mountain View, United States.
What are the core technical features of Kardia personal ECG devices (KardiaMobile?
Documented capabilities include: Kardia personal ECG devices (KardiaMobile, KardiaMobile 6L, Kardia 12L) and KAI AI algorithms detecting arrhythmias, isch KardiaPro and KardiaStation enterprise software for provider monitoring and clinical trials; KAI 12L applies deep learning to reduced; lead ECG acquisitions, detecting conditions historically requiring full 12.
What machine learning stack powers Kardia personal ECG devices (KardiaMobile?
Kardia personal ECG devices (KardiaMobile utilizes Machine Learning, Deep Learning, Predictive Analytics, Healthcare Analytics, supporting deployment across air-gapped biomedical research clusters with encrypted enclaves.
Which organizations deploy Kardia personal ECG devices (KardiaMobile?
The software is engineered for Consumers, employers, health systems, life-sciences sponsors, and veterans health programs needing portable ECG acquisition with AI interpretation in outpatient, acute, and remote monitoring settings. seeking to mitigate clinical workflow latency and diagnostic data fragmentation.
Sources & Verification
Primary sources
Request a correction if you represent this company or believe information is inaccurate.
Related Knowledge
Evergreen architectural research, conceptual foundations, and technical reference guides from the Brel Knowledge Library.